A group of academic, biotech, biopharma, and healthcare leaders at Harvard and across Massachusetts plan to create a new center for innovation and manufacturing next-generation medicines, according to a Monday press release.
The center, which is estimated to cost $50 million dollars, will be an independent non-profit located in the Greater Boston area. The board of directors of the new center includes leaders from Harvard, MIT, Fujifilm Diosynth Biotechnologies, GE Healthcare Life Sciences, and Alexandria Real Estate Equities, Inc.
Image: Senior members of Harvard’s central administration, including University Provost Alan M. Garber ’76, work in Massachusetts Hall. Photo: Sydney R. Mason
{iframe}https://www.thecrimson.com/article/2019/11/25/new-health-and-medicine-center/{/iframe}